Prochlorperazine-induced neuroleptic malignant syndrome.
Neuroleptic malignant syndrome can present in a variety of ways. In a review of the medical literature we could find few well-documented reports of prochlorperazine-induced neuroleptic malignant syndrome. We report such a case with its workup, recognition, and management.
Pesola
G R
GR
Department of Emergency Medicine, St. Vincent's Hospital, New York, New York, USA.
Quinto
C
C
D000138:Acidosis / Q000150:complications; D000328:Adult; D000932:Antiemetics / Q000009:adverse effects*; D001971:Bromocriptine / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy / Q000209:etiology*; D011346:Prochlorperazine / Q000009:adverse effects*
D000932:Antiemetics; D018492:Dopamine Antagonists; D001971:Bromocriptine; D011346:Prochlorperazine